Business Context and Reporting Period
This Form 8-K Current Report was filed by Harvard Bioscience, Inc. (HBIO) on March 6, 2020, covering events occurring on March 2, 2020. The filing discloses the entry into a material definitive agreement with Chane Graziano, the Company's former Chief Executive Officer.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a corporate governance agreement and does not contain financial performance data.
Material Changes
The primary material change reported is the execution of a Consulting Agreement between Harvard Bioscience, Inc. and Chane Graziano. Key terms include:
- Role: Mr. Graziano will consult with the Company as requested.
- Compensation: The Company will reimburse reasonable out-of-pocket travel expenses; no base salary or equity grant is detailed in the summary text.
- Voting Rights: Mr. Graziano agreed to vote all shares of common stock beneficially owned by him in accordance with the Board of Directors' recommendations.
- Ownership: Mr. Graziano is the beneficial owner of approximately 2.5 million shares of common stock (excluding shares owned by family members not controlled by him).
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, outlook, management commentary on financial performance, or specific risk factors beyond the standard incorporation of the agreement by reference. The agreement itself is attached as Exhibit 10.1.
Investor Verification Checklist
- Verify the full terms of the Consulting Agreement in Exhibit 10.1, specifically regarding any potential future compensation or termination clauses not summarized in Item 1.01.
- Confirm the exact number of shares beneficially owned by Chane Graziano and whether the 2.5 million figure represents a change from prior beneficial ownership reports.
- Review the Company's recent 10-K or 10-Q filings for the most current financial position, as this 8-K contains no financial metrics.
- Monitor subsequent filings for any updates on Mr. Graziano's consulting activities or voting actions.